Trials / Recruiting
RecruitingNCT07083999
Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility
Prospective Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility Food Supplement Containing a Combination of MYO/DCI in a 3.6:1 Ratio, Antioxidants, Vitamins and Minerals
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Procare Health Iberia S.L. · Industry
- Sex
- Female
- Age
- 32 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to evaluate whether supplementation with the Ovosicare® Fertility food supplement increases the possibility of becoming pregnant in women aged between 32 and 38 years who have been trying to become pregnant for at least 6 months before starting supplementation.
Detailed description
The duration of participation in the study for each patient will be a maximum of 18 months. This follow-up period may be shorter if a pregnancy occurs. The number of visits throughout the study will be a total of three. Please note that you will not have to undergo additional tests or attend any extraordinary visits due to participating in this study, since the procedures you will undergo are the same as those routinely carried out in clinical practice.
Conditions
Timeline
- Start date
- 2025-02-13
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
- First posted
- 2025-07-24
- Last updated
- 2025-07-24
Locations
27 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT07083999. Inclusion in this directory is not an endorsement.